|
何计南, 肖海清, 田政湘. 尿毒症维持性透析患者睡眠状况及影响因素分析 [J]. 重庆医学, 2010, (11):1425.doi: 10.3969/j.issn.1671-8348.2010.11.047.
|
|
吴甫民. 血液透析联合血液灌流治疗尿毒症70例观察 [J]. 中国现代医药杂志, 2011(3):44.doi: 10.3969/j.issn.1672-9463.2011.03.015.
|
|
辜凯. 血液透析串联血液灌流治疗尿毒症的临床观察 [J]. 中国医药导报, 2011, (24):54.doi: 10.3969/j.issn.1673-7210.2011.24.022.
|
|
丁德良, 李环波. 尿毒症患者C反应蛋白与贫血、营养不良及冠心病的关系 [J]. 实用医学杂志, 2006, (17):2026.doi: 10.3969/j.issn.1006-5725.2006.17.029.
|
|
王景福. 维持性血液透析患者的微炎症状态 [J]. 承德医学院学报, 2011(2):197.doi: 10.3969/j.issn.1004-6879.2011.02.050.
|
|
Chen S J, JiangGR, Shan J P. Combination of maintenance hemodialysis with hemoperfusion:a safe and effective model of artificial kidney [J]. International Journal of Artificial Organs, 2011(4):339.
|
|
Tojimbara T, Sato S, Nakajima I. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure [J]. Therapeutic Apheresis and Dialysis, 2004(4):286.
|
|
Winchester J F, Ronco C, Brady J A. Rationale for combined hemoperfusion/hemodialysis in uremia [J]. Contributions to Nephrology, 2001, (133):174.
|
|
Samatskaya V V, Yushko L A, Sakhno L A. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients [J]. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 2007(3):287.
|
|
Chen L H, Zhuang L, Zhang L Q. Clinical analysis of hemodialysis combined with hemoperfusion for treatment in uremic patients [J]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2010, (12):760.
|
|
Shafik A, Saleh M, Mahmoud A. Homohemodialysis:a technique of dialysis for the uremic animal [J]. Biomedical Sciences Instrumentation, 1997.509.
|
|
李聪, 陈楠. 炎症在维持性血液透析患者血管内皮损伤中作用及抗感染治疗 [J]. 中国血液净化, 2011(2):100.doi: 10.3969/j.issn.1671-4091.2011.02.012.
|
|
Taniguchi T, Takemoto Y, Tsuda K. Effects of posttreatment with direct hemoperfusion using a CTR column on mortality and inflammatory responses to endotoxin-induced shock in rats [J]. Blood Purification, 2006, (5/6):460.
|
下载:
苏公网安备 32100302010246号
